A systemic view of Alzheimer disease—insights from amyloid-β metabolism beyond the brain

J Wang, BJ Gu, CL Masters, YJ Wang - Nature reviews neurology, 2017 - nature.com
Alzheimer disease (AD) is the most common type of dementia, and is currently incurable;
existing treatments for AD produce only a modest amelioration of symptoms. Research into …

Re‐imagining Alzheimer's disease–the diminishing importance of amyloid and a glimpse of what lies ahead

KH Tse, K Herrup - Journal of neurochemistry, 2017 - Wiley Online Library
Many have criticized the amyloid cascade hypothesis of Alzheimer's disease for its
inconsistencies and failures to either accurately predict disease symptoms or guide the …

Alzheimer's disease: a general introduction and pathomechanism

VH Finder - Journal of Alzheimer's disease, 2010 - content.iospress.com
Alzheimer's disease (AD) is the most common form of dementia, which affects more than 35
million people worldwide with increasing tendency. Satisfying therapies and prevention are …

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

T Guo, D Zhang, Y Zeng, TY Huang, H Xu… - Molecular …, 2020 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder seen in age-
dependent dementia. There is currently no effective treatment for AD, which may be …

Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

SW Pimplikar, RA Nixon, NK Robakis… - Journal of …, 2010 - Soc Neuroscience
Despite the progress of the past two decades, the cause of Alzheimer's disease (AD) and
effective treatments against it remain elusive. The hypothesis that amyloid-β (Aβ) peptides …

The therapeutics of Alzheimer's disease: where we stand and where we are heading

DJ Selkoe - Annals of neurology, 2013 - Wiley Online Library
Few diagnoses in modern medicine evoke more apprehension in patients and their families
than Alzheimer disease (AD). Defined as a clinical and pathological entity a century ago, the …

Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Aβ amyloid pathway

CL Masters, K Beyreuther - Brain, 2006 - academic.oup.com
It is now 100 years since the nosological definition of Alzheimer's disease emerged. In the
first 80 years, very little progress was made in understanding the mechanisms that caused …

On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis

MA Castello, S Soriano - Ageing research reviews, 2014 - Elsevier
The amyloid cascade hypothesis, which implicates the amyloid Aβ peptide as the
pathological initiator of both familial and sporadic, late onset Alzheimer's disease (AD) …

Alzheimer's disease mechanisms and emerging roads to novel therapeutics

C Sala Frigerio, B De Strooper - Annual review of neuroscience, 2016 - annualreviews.org
Ten years of remarkable progress in understanding the fundamental biochemistry of
Alzheimer's disease have been followed by ten years of remarkable and increasing clinical …

Ten challenges of the amyloid hypothesis of Alzheimer's disease

KP Kepp - Journal of Alzheimer's Disease, 2017 - content.iospress.com
The inability to effectively halt or cure Alzheimer's disease (AD), exacerbated by the recent
failures of high-profile clinical trials, emphasizes the urgent need to understand the complex …